1257 related articles for article (PubMed ID: 24954834)
41. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
[TBL] [Abstract][Full Text] [Related]
42. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
[TBL] [Abstract][Full Text] [Related]
43. The role of neuroimaging in mild cognitive impairment.
Matsuda H
Neuropathology; 2007 Dec; 27(6):570-7. PubMed ID: 18021379
[TBL] [Abstract][Full Text] [Related]
44. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
Mosconi L; Andrews RD; Matthews DC
J Alzheimers Dis; 2013; 35(3):509-24. PubMed ID: 23478305
[TBL] [Abstract][Full Text] [Related]
45. Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
Waragai M; Mizumura S; Yamada T; Matsuda H
Dement Geriatr Cogn Disord; 2008; 26(6):547-55. PubMed ID: 19066428
[TBL] [Abstract][Full Text] [Related]
46. [Novel neuroimaging perspectives in the diagnosis of dementia].
Jessen F
Nervenarzt; 2008 Nov; 79 Suppl 3():129-36; quiz 137. PubMed ID: 18830576
[TBL] [Abstract][Full Text] [Related]
47. Effect of white matter lesions on brain perfusion in Alzheimer's disease.
Kimura N; Nakama H; Nakamura K; Aso Y; Kumamoto T
Dement Geriatr Cogn Disord; 2012; 34(3-4):256-61. PubMed ID: 23183589
[TBL] [Abstract][Full Text] [Related]
48. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
49. White matter hyperintensities predict amyloid increase in Alzheimer's disease.
Grimmer T; Faust M; Auer F; Alexopoulos P; Förstl H; Henriksen G; Perneczky R; Sorg C; Yousefi BH; Drzezga A; Kurz A
Neurobiol Aging; 2012 Dec; 33(12):2766-73. PubMed ID: 22410648
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of brain perfusion single-photon emission tomography images using an easy Zscore imaging system for early diagnosis of Alzheimer's disease].
Wang S; Qi Y; Jiang Y; Chi X; Huang K; Ruan C; Yang X; Li G
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1093-1100. PubMed ID: 34308862
[TBL] [Abstract][Full Text] [Related]
51. Clinically different stages of Alzheimer's disease associated by amyloid deposition with [11C]-PIB PET imaging.
Hatashita S; Yamasaki H
J Alzheimers Dis; 2010; 21(3):995-1003. PubMed ID: 20693641
[TBL] [Abstract][Full Text] [Related]
52. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
[TBL] [Abstract][Full Text] [Related]
53. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
[TBL] [Abstract][Full Text] [Related]
54. Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease.
Trzepacz PT; Hochstetler H; Yu P; Castelluccio P; Witte MM; Dell'Agnello G; Degenhardt EK;
Dement Geriatr Cogn Disord; 2016; 41(1-2):68-79. PubMed ID: 26625159
[TBL] [Abstract][Full Text] [Related]
55. Amyloid imaging.
Villemagne VL; Rowe CC
Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S41-9. PubMed ID: 21729418
[TBL] [Abstract][Full Text] [Related]
56. Autopsy-confirmed hippocampal-sparing Alzheimer's disease with delusional jealousy as initial manifestation.
Fujishiro H; Iritani S; Hattori M; Sekiguchi H; Matsunaga S; Habuchi C; Torii Y; Umeda K; Ozaki N; Yoshida M; Fujita K
Psychogeriatrics; 2015 Sep; 15(3):198-203. PubMed ID: 25737011
[TBL] [Abstract][Full Text] [Related]
57. The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies.
Ferreira LK; Tamashiro-Duran JH; Squarzoni P; Duran FL; Alves TC; Buchpiguel CA; Busatto GF
Braz J Psychiatry; 2014; 36(4):344-57. PubMed ID: 24918525
[TBL] [Abstract][Full Text] [Related]
58. PET of brain amyloid and tau in mild cognitive impairment.
Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
[TBL] [Abstract][Full Text] [Related]
59. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
[TBL] [Abstract][Full Text] [Related]
60. Imaging of Alzheimer's disease.
Lee BC; Mintun M; Buckner RL; Morris JC
J Neuroimaging; 2003 Jul; 13(3):199-214. PubMed ID: 12889165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
